Compare
Pit 2–4 stocks against each other: U-Score, pillars, fundamentals, and normalized price history. Same universe, same methodology, one view.
| Metric | NEULANDLAB Neuland Laboratories Limited Pharma · Small | PPLPHARMA Piramal Pharma Limited Pharma · Small | WOCKPHARMA Wockhardt Limited Pharma · Small | PINELABS Pine Labs Limited Pharma · Small |
|---|---|---|---|---|
| Final Score | 48 | 24 | 19 | 32 |
| Verdict | FAIR VALUE | OVERVALUED | OVERVALUED | WATCHLIST |
| Style | Financial Turnaround | OVERVALUED | OVERVALUED | WATCHLIST |
| Piotroski | 8/9 | 5/9 | 8/9 | 8/9 |
| Valuation | 0/30 | 5/30 | 0/30 | 2/30 |
| Growth | 17/25 | 3/25 | 4/25 | 15/25 |
| Quality | 14/20 | 0/20 | 0/20 | 0/20 |
| Balance Sheet | 8/15 | 6/15 | 6/15 | 8/15 |
| Cash Flow | 4/10 | 7/10 | 4/10 | 1/10 |
| Price | ₹17,200 | ₹168.87 | ₹1,887.6 | ₹152.36 |
| P/E | 59.80 | — | 108.00 | 143.00 |
| P/B | 11.61 | 2.69 | 6.23 | 2.79 |
| ROE | 21.40% | -3.58% | 6.11% | 2.46% |
| ROCE | 26.60% | 2.69% | 7.55% | 4.16% |
| Debt / Equity | 0.16 | 0.70 | 0.45 | 0.07 |
| FCF Yield | — | 3.76% | 0.48% | — |
| Dividend Y | 0.20% | 0.08% | — | — |
| Altman Z | 8.27 | 2.71 | 6.66 | 2.39 |
| Promoter % | 32.63% | 34.85% | 49.09% | — |
| Mkt Cap (₹Cr) | 21762.00 | 22013.00 | 30758.00 | 16400.00 |
| Graham # | ₹3,053.89 | — | ₹299.45 | ₹33.63 |
| Fair PE | 42.0 | 0.7 | 2.6 | 42.0 |
| MoS % | -44.4% | — | -5524.2% | -270.2% |
Normalized price (3-year, indexed to 100)
Higher line = better relative performance from startNEULANDLAB125
PPLPHARMA60
WOCKPHARMA153
PINELABS61